OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 11 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,577,000 | +3943.6% | 83,046 | +2763.7% | 0.00% | – |
| Q4 2018 | $39,000 | -29.1% | 2,900 | -41.0% | 0.00% | – |
| Q3 2018 | $55,000 | -33.7% | 4,914 | -70.9% | 0.00% | – |
| Q4 2016 | $83,000 | +27.7% | 16,874 | +28.5% | 0.00% | – |
| Q3 2016 | $65,000 | -17.7% | 13,128 | -15.8% | 0.00% | – |
| Q2 2016 | $79,000 | +14.5% | 15,586 | +29.2% | 0.00% | – |
| Q1 2016 | $69,000 | -65.3% | 12,067 | -37.0% | 0.00% | – |
| Q4 2015 | $199,000 | -13.9% | 19,163 | +52.9% | 0.00% | – |
| Q3 2015 | $231,000 | -9.1% | 12,531 | -4.0% | 0.00% | – |
| Q2 2015 | $254,000 | +38.8% | 13,050 | +25.1% | 0.00% | – |
| Q1 2015 | $183,000 | -6.6% | 10,433 | -15.0% | 0.00% | – |
| Q4 2014 | $196,000 | +28.9% | 12,267 | +1.3% | 0.00% | – |
| Q3 2014 | $152,000 | -3.8% | 12,113 | +20.3% | 0.00% | – |
| Q2 2014 | $158,000 | +29.5% | 10,067 | +8.4% | 0.00% | – |
| Q1 2014 | $122,000 | -35.4% | 9,290 | -21.0% | 0.00% | – |
| Q4 2013 | $189,000 | -80.3% | 11,756 | -79.6% | 0.00% | – |
| Q3 2013 | $957,000 | +505.7% | 57,509 | +266.3% | 0.00% | – |
| Q2 2013 | $158,000 | – | 15,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|